APPENDIX 2
Ailingnae Group and Control Mean Blood Counts by Day and by Age
WBC
(x10)
Neutrophils
(«1079)
Lymphocytes
Platelets
(x10")
Monocytes
(x 10-*)
(x 10-7)
Eosinophils
(x 10°")
Male
Male
Female
Total
Postexposure day
<5
>5
<5
35
<5
35
<10
>10
allages
group
<5
>5
<5
>5
3
7
10
12
15
18
22
26
30
6.0
5.5
63
6.3
7.1
68
8.9
84
96
70
68
7.3
7.6
70
78
8.7
70
86
3.0
—
42
18
2.3
29
5.3
48
53
5.0
—
42
4.7
45
5.0
5.4
44
62
2.8
19
3.1
4.2
3.5
2.7
3.2
3.7
2.2
—
2.2
2.2
2.2
2.4
29
2.2
2.0
_—
_
22.5
_
29.0
27.5
23.5
20.0
19.5
_
—
22.6
—
20.2
21.7
17.0
13.8
12.8
_
—
20.9
—
24.6
24.9
22.9
17.4
18.2
_
—
21.5
_—
23.9
24.3
21.3
16.7
16.8
0.8
-_
38
3.4
3.7
2.3
15
2.3
19
1.6
=
2.1
5.8
26
1.5
24
2.4
619
05
_2.6
44
2.3
3.2
-3.8
0.6
4.1
0.4
=
1.6
26
La
23
24
16
20
39
43
47
51
7.5
6.9
7.3
8.4
6.2
65
6.7
6.3
2.9
2.7
3.5
3.8
4.2
3.6
3.8
3.6
4.7
39
3.4
40
19
27
27
2.2
26.5
28.0
27.0
32.0
20.8
19.6
20.0
18.2
27.0
25.3
26.1
25.0
25.2
24,0
24.5
23.9
11047
0.6
1.4
2.2
1.9
2.7
28
7.7
65
48
3.9
2.7
2.2
25.2
19.2
239
22.7
L.1
11.1
7.8
4.2
4.7
7.0
4.4
33
34
6-mo survev
|-vr survey
7.7)
46
7.8
63
2-vr survey
3-vr survey
4-yr survey
J-vr survey
6-vr survey
Majuro controls
11.0
12.1
11.5
—
2
91
7.0
7.5
Yi
7.3
9.7
Rita controls. 2 vr
14.1
89
Rongelapcontrols, 3 vr
Rongelapcontrols, 4 vr
Rongelap controls, 3 vr
9.8 69
11.2 80
13.7 10.1
3.3
28
49
3.3
28
—
—
48
40
40
6.2
5.2
3.5
5.1
3.9
37
3.1
3.6
48
34
3.6
3.2
3.5
32
6.5
48
3.6
7.0
—
—
7400
5.6
4.7
6.2
62
?.2
35
5.6
3.2
2.6
33
3.7
320
41
3.6
2.9
3.7
4.1
62
24.0
37.0)
38.7
51.2
40.8
33.2
40.9
—
41.2
33.5
32.6
38.8
35.8
15.8
19.8
21.4
17.4
22.4
24.7
26.3
—
25.8
24.2
26.9
30.7
28.0
22.7
23.8
17.6
24.2
28.3
27.5
31,2
29.5
26.4
31.2
33.6
20.8
—
36.5
30.0
34.0
33.6
26.7
—
—
—
—
33.4
—
—
—
2.8
2.2
1.5
1.9
1.0
1.1
3.6
30
2.2
—
—
20
i
14
2.30
3.7
14
Lt
07
1
3.2
O04
2.0
1.5
0.7
11
24
60
19
27
16
28 0.6
1.5° 07
2.2
1.0
18
O8
1.7
22
12.8
66
hoo
2
96 64
3.30037
1260 4.2
~
60
—
40
95
4.7
6.2
70°
6.2
4.0
435
6.0